Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Tyra Biosciences, Inc. - Common Stock (NQ:TYRA)

34.66 +0.78 (+2.30%)
Streaming Delayed Price Updated: 3:05 PM EST, Feb 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 443,291
Open 34.00
Bid (Size) 34.52 (300)
Ask (Size) 34.67 (100)
Prev. Close 33.88
Today's Range 33.87 - 35.71
52wk Range 6.420 - 34.07
Shares Outstanding 43,010,692
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer ↗
Agios Pharmaceuticals develops therapies for rare blood disorders, anchored by its PYRUKYND franchise and early-stage clinical programs. 
Via The Motley Fool
News headline image
Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake ↗
Viridian Therapeutics develops monoclonal antibody therapies targeting rare diseases, with a focus on thyroid eye disease treatments. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+29.4%
+29.4%
1 Month
+14.9%
+14.9%
3 Month
+58.3%
+58.3%
6 Month
+174.2%
+174.2%
1 Year
+170.4%
+170.4%

More News

Read More
News headline image
Spyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Tyra Biosciences Narrows Loss in Q2 ↗
Via The Motley Fool
News headline image
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
News headline image
Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Why WaFd Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Neumora Therapeutics, XPeng And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Why Is Cancer-Focused Tyra Biosciences Stock Falling On Friday? ↗
Via Benzinga
News headline image
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug ↗
Via Benzinga
News headline image
This Datadog Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday ↗
Via Benzinga
News headline image
TYRA Investors Have Opportunity to Join Tyra Biosciences, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
TYRA Stock Earnings: Tyra Biosciences Beats EPS for Q2 2024 ↗
Via InvestorPlace
News headline image
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
TYRA Stock Earnings: Tyra Biosciences Beats EPS for Q1 2024 ↗
Via InvestorPlace

Frequently Asked Questions

Is Tyra Biosciences, Inc. - Common Stock publicly traded?
Yes, Tyra Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Tyra Biosciences, Inc. - Common Stock trade on?
Tyra Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tyra Biosciences, Inc. - Common Stock?
The ticker symbol for Tyra Biosciences, Inc. - Common Stock is TYRA on the Nasdaq Stock Market
What is the current price of Tyra Biosciences, Inc. - Common Stock?
The current price of Tyra Biosciences, Inc. - Common Stock is 34.66
When was Tyra Biosciences, Inc. - Common Stock last traded?
The last trade of Tyra Biosciences, Inc. - Common Stock was at 02/25/26 03:05 PM ET
What is the market capitalization of Tyra Biosciences, Inc. - Common Stock?
The market capitalization of Tyra Biosciences, Inc. - Common Stock is 1.49B
How many shares of Tyra Biosciences, Inc. - Common Stock are outstanding?
Tyra Biosciences, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.